edward
e
walsh
acut
bronchiti
refer
clinic
syndrom
distinguish
rel
brief
selflimit
inflammatori
process
larg
midsiz
airway
associ
evid
pneumonia
chest
radiographi
character
dri
product
cough
less
week
durat
preval
winter
primarili
caus
virus
definit
pertain
acut
exacerb
chronic
bronchiti
clinic
syndrom
also
frequent
associ
viral
infect
bacteria
play
import
role
see
chapter
also
distinguish
acut
bronchiol
clinic
syndrom
involv
small
airway
close
link
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
infect
infant
see
chapter
acut
cough
one
common
reason
physician
visit
age
group
incid
data
may
imprecis
symptom
overlap
consider
common
cold
pneumonia
asthma
estim
nation
health
interview
survey
us
household
found
overal
person
annual
report
physiciandiagnos
acut
bronchiti
highest
rate
winter
month
younger
age
year
studi
unit
kingdom
report
similar
rate
per
person
rang
per
younger
men
per
older
year
age
microbi
etiolog
despit
fail
uncov
specif
pathogen
case
seri
acut
bronchiti
believ
commonli
caus
wide
rang
virus
tabl
approxim
less
case
attribut
bacteri
pathogen
princip
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
pertussi
howev
recent
increas
pertussi
case
among
adolesc
adult
consid
evalu
ill
rel
proport
case
caus
differ
pathogen
vari
accord
age
season
studi
importantli
also
influenc
diagnost
method
use
molecular
test
rather
standard
cultur
identifi
greater
number
wider
rang
viral
pathogen
especi
adult
mani
ill
repres
reinfect
common
pediatr
virus
rsv
hmpv
parainfluenza
virus
infect
newli
discov
pathogen
parainfluenza
bocaviru
mani
infect
adult
associ
low
viru
shed
furthermor
present
physician
viru
shed
may
alreadi
ceas
influenza
b
virus
close
associ
winter
outbreak
acut
bronchiti
children
adult
high
rel
incid
infect
effici
influenza
viru
infect
damag
bronchiolar
epitheli
cell
although
cough
associ
coronaviru
rhinoviru
infect
commonli
caus
postnas
congest
agent
includ
recent
identifi
strain
rhinoviru
coronaviru
includ
sever
acut
respiratori
syndrom
infect
lower
airway
caus
acut
bronchiti
higher
temperatur
lower
airway
consid
inhospit
rhinoviru
replic
howev
recent
evid
convincingli
document
viru
presenc
bronchiolar
epitheli
cell
although
cytopatholog
less
influenza
viru
infect
although
found
less
frequent
virus
gener
popul
adenovirus
includ
recent
identifi
adenoviru
type
adenoviru
type
import
caus
bronchiti
militari
recruit
enterovirus
primarili
echoviru
coxsackieviru
caus
acut
bronchiti
simultan
infect
two
virus
occur
case
frequent
case
bocaviru
infect
worldwid
measl
viru
remain
import
respiratori
tract
pathogen
caus
cough
earli
prodrom
phase
especi
vulner
malnourish
children
develop
countri
lack
resourc
vaccin
although
herp
simplex
viru
commonli
identifi
respiratori
secret
patient
respiratori
ill
gener
consid
clinic
insignific
associ
occas
acut
hemorrhag
tracheobronch
normal
definit
acut
bronchiti
selflimit
syndrom
character
acut
cough
without
sputum
without
sign
pneumonia
acut
bronchiti
occur
yearround
caus
larg
number
respiratori
pathogen
accord
typic
epidemiolog
pathogen
diagnosi
primarili
made
clinic
present
absenc
sign
symptom
pneumonia
therapi
symptomat
antibiot
uncommonli
requir
unnecessari
major
case
prevent
direct
specif
pathogen
possibl
eg
influenza
pertussi
vaccin
person
describ
critic
ill
intub
adult
although
occasion
involv
lower
airway
infect
human
papillomaviru
type
produc
symptom
hoars
stridor
chronic
cough
mycoplasma
pneumonia
c
pneumonia
bordetella
pertussi
bacteria
associ
acut
bronchiti
implic
perhap
case
cough
caus
agent
especi
b
pertussi
may
persist
case
sever
month
recent
bordetella
holmesii
recogn
caus
pertussi
syndrom
see
chapter
recent
acellular
pertussi
vaccin
trial
adult
incid
pertussi
placebo
group
howev
number
case
adult
increas
recent
year
attribut
incomplet
vaccin
uptak
well
failur
vaccin
induc
durabl
immun
result
recommend
provid
vaccin
booster
dose
adult
pregnant
women
see
chapter
bordetella
bronchiseptica
canin
pathogen
occasion
caus
diseas
human
especi
immunocompromis
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
formerli
branhamella
catarrhali
conclus
demonstr
caus
acut
bronchiti
despit
implic
postvir
pneumonia
chronic
bronchiti
although
mani
virus
enhanc
bacteri
adher
respiratori
epitheli
cell
vitro
actual
incid
postvir
bacteri
infect
clinic
situat
well
defin
pathogenesi
acut
bronchiti
result
combin
direct
cytopatholog
pathogen
host
immun
respons
cell
tropism
pathogen
mechan
vari
virus
surpris
locat
extent
cytopatholog
airway
also
vari
histopatholog
chang
airway
infect
best
character
influenza
viru
recent
autopsi
seri
children
fatal
influenza
submucos
congest
hemorrhag
mononuclear
cell
infiltr
epitheli
necrosi
note
case
similar
find
report
adult
along
occlus
airway
desquam
necrot
debri
less
sever
influenza
bronchoscop
examin
reveal
mild
inflammatori
chang
rsv
also
demonstr
infect
termin
bronchiolar
line
cell
extens
debri
occlud
lumen
infant
similar
data
lack
adult
rhinoviru
primarili
associ
upper
respiratori
common
cold
symptom
produc
patchi
infect
bronchial
epitheli
cell
day
experiment
challeng
ampl
evid
immun
respons
contribut
significantli
diseas
pathogenesi
acut
bronchiti
innat
immun
respons
character
virusinduc
releas
proinflammatori
cytokin
chemokin
respiratori
epitheli
cell
immun
cell
contribut
system
local
symptom
earli
infect
influenza
type
interferon
tumor
necrosi
factor
detect
experiment
influenza
viru
infect
symptom
correl
tempor
kinet
cytokin
secret
cytokin
induct
rhinoviru
may
also
explain
import
role
viru
play
asthma
episod
immun
respons
thought
like
respons
prolong
airway
hyperreact
demonstr
week
influenza
rsv
infect
normal
adult
among
bacteri
caus
acut
bronchiti
b
pertussi
uniqu
express
toxin
may
play
role
clinic
symptom
includ
prolong
characterist
cough
howev
defin
specif
pertussi
cough
toxin
yet
identifi
children
adult
acut
bronchiti
begin
sign
symptom
typic
common
cold
syndrom
nasal
congest
rhiniti
sore
throat
malais
lowgrad
fever
typic
common
respiratori
viral
pathogen
note
first
follow
shortli
onset
cough
becom
domin
sign
acut
bronchiti
mild
case
ill
last
day
wherea
other
cough
may
persist
week
longer
wheez
uncommon
acut
bronchiti
one
studi
netherland
patient
acut
bronchiti
ultim
diagnos
asthma
diseas
sever
domin
variou
symptom
may
vari
accord
specif
pathogen
fever
common
higher
influenza
adenoviru
infect
compar
rhinoviru
rsv
infect
age
contrast
rsvor
hmpvinfect
person
like
wheez
influenza
virusinfect
patient
variou
host
factor
age
underli
medic
condit
immun
statu
environment
factor
secondhand
smoke
exposur
influenc
clinic
present
ill
sever
older
patient
underli
cardiopulmonari
condit
infect
influenza
rsv
hmpv
remain
ill
averag
day
contrast
younger
person
whose
ill
last
averag
day
pneumonia
infect
cough
serolog
larg
number
potenti
pathogen
caus
acut
bronchiti
newer
rapid
multiplex
rtpcr
assay
could
provid
use
diagnost
inform
manag
acut
bronchiti
therapi
patient
acut
bronchiti
gener
symptomat
direct
relief
troublesom
upper
respiratori
symptom
cough
wheez
note
acut
bronchiti
asthma
present
similar
manifest
therapi
direct
toward
bronchospasm
may
requir
sever
approach
control
acut
cough
includ
narcot
cough
suppress
expector
antihistamin
decongest
agonist
review
random
control
trial
clearli
conclud
benefici
placebocontrol
doubleblind
trial
experiment
rhinoviru
infect
combin
ibuprofen
mg
plu
chlorpheniramin
mg
administ
everi
hour
day
reduc
cough
significantli
although
effect
optim
combin
intranas
antivir
compound
introduct
antibacteri
agent
rapidli
embrac
treatment
acut
bronchiti
current
patient
receiv
antibiot
diagnosi
howev
empir
antibacteri
therapi
acut
bronchiti
without
regard
demonstr
pathogenspecif
therapi
repeatedli
shown
provid
benefit
patient
howev
acut
bronchiti
remain
one
five
frequent
cite
rational
excess
antibiot
use
outpati
acut
bronchiti
acut
respiratori
syndrom
otiti
media
sinus
pharyng
upper
respiratori
tract
infect
account
approxim
ambulatori
prescript
unit
state
current
guidelin
endors
number
nation
societi
includ
infecti
diseas
societi
america
recommend
routin
use
antibiot
uncompl
acut
bronchiti
otherwis
normal
person
variou
strategi
reduc
antibiot
use
includ
patient
physician
educ
delay
prescript
fill
reduc
antibiot
use
approxim
recent
random
control
studi
use
level
serum
procalcitonin
guid
therapi
acut
respiratori
infect
includ
acut
bronchiti
also
demonstr
antibiot
use
partli
reduc
without
advers
affect
outcom
specif
viral
diagnosi
confirm
use
rapid
rtpcr
test
perhap
physician
would
will
forego
antibiot
treatment
even
patient
document
pneumonia
c
pneumonia
infect
may
benefit
specif
therapi
macrolid
quinolon
absenc
pneumonia
adult
adolesc
earli
therapi
infect
b
pertussi
macrolid
tetracyclin
indic
prevent
transmiss
although
clinic
find
earli
infect
indistinguish
viral
caus
bronchiti
may
use
seek
specif
diagnosi
influenza
commun
outbreak
specif
treatment
neuraminidas
inhibitor
activ
influenza
b
strain
reduc
durat
ill
administ
earli
cours
one
studi
adult
influenza
subsequ
antibacteri
use
zanamivirtr
patient
compar
placebotr
control
howev
bacteriolog
radiolog
confirm
bacteri
pneumonia
sought
studi
prevent
measur
reduc
transmiss
agent
known
caus
acut
bronchiti
limit
standard
respiratori
contact
precaut
specif
etiolog
unknown
immun
specif
pathogen
influenza
pertussi
benefit
reduc
incid
symptomat
infect
agent
see
chapter
particularli
persist
irrit
often
minim
phlegm
caus
sever
chest
discomfort
acut
bronchiti
suspect
person
acut
respiratori
tract
ill
cough
domin
complaint
patient
evalu
begin
care
histori
includ
identif
underli
chronic
obstruct
pulmonari
diseas
asthma
may
requir
specif
therapi
take
note
season
presenc
influenza
circul
virus
commun
import
commun
outbreak
influenza
presenc
acut
ill
fever
cough
predict
valu
young
healthi
person
among
hospit
older
person
acut
respiratori
tract
ill
similar
clinic
paramet
increas
odd
influenza
approxim
threefold
exposur
environment
irrit
sought
especi
absenc
typic
upper
respiratori
tract
symptom
travel
histori
exposur
ill
famili
member
close
contact
may
provid
use
inform
incub
period
thu
etiolog
pneumonia
incub
period
day
progress
slowli
famili
contrast
influenza
incub
period
close
cluster
ill
recent
vaccin
elimin
influenza
consider
especi
older
person
protect
efficaci
poor
prolong
cough
longer
week
without
paroxysm
vomit
suggest
b
pertussi
even
among
vaccin
adolesc
adult
immun
durabl
physic
examin
attent
sign
pneumonia
primari
goal
evalu
discrimin
acut
bronchiti
pneumonia
concern
clinician
occurr
bacteri
infect
follow
viral
respiratori
tract
infect
best
exemplifi
sever
bacteri
pneumonia
follow
influenza
infect
pandem
similarli
one
report
describ
bacterem
pneumonia
pneumonia
longterm
care
patient
anteced
parainfluenza
viru
infect
despit
concern
postvir
bacteri
pneumonia
sever
larg
studi
indic
approxim
patient
diagnos
acut
bronchiti
radiograph
evid
pneumonia
combin
sign
symptom
overal
clinic
judgment
imprecis
sensit
one
studi
found
absenc
vital
sign
abnorm
radiograph
evalu
could
safe
omit
standard
laboratori
test
white
blood
cell
count
inflammatori
marker
serum
creactiv
protein
reliabl
discrimin
viral
bacteri
infect
howev
recent
studi
europ
suggest
serum
procalcitonin
level
ngml
may
reliabl
indic
patient
varieti
acut
respiratori
syndrom
includ
acut
bronchiti
requir
antibiot
therapi
procalcitonin
prohormon
calcitonin
synthes
varieti
tissu
respons
bacteri
infect
greater
extent
viral
infect
ultim
etiolog
diagnosi
requir
laboratori
confirm
rapid
antigen
detect
nasopharyng
swab
rel
sensit
influenza
viru
age
group
rsv
infant
identif
viral
pathogen
requir
tissu
cultur
reversetranscriptas
polymeras
chain
reaction
rtpcr
assay
latter
especi
use
older
adult
cultur
mani
preval
virus
rsv
hmpv
coronavirus
parainfluenza
virus
insensit
adult
diagnosi
pneumonia
rest
demonstr
pathogenspecif
igm
serum
rtpcr
assay
b
pertussi
diagnosi
made
serolog
rtpcr
assay
cultur
c
pneumonia
difficult
diagnos
requir
rtpcr
assay
complet
refer
list
avail
onlin
expert
consult
